VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1823943
Sex: F
Age:
State: OH

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Muscle pain; joint pain; nausea; Headache; weakness; fatigue; injection site pain; flu like aches; Pains; This is a spontaneous report from a contactable consumer or other non hcp. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: Pfizer6207) via an unspecified route of administration in the arm left on 05Apr2021 at 13:15 (at the age of 63-year-old) as dose 2, single for COVID-19 immunisation. Medical history included Known allergy: penicillin. Concomitant medications included buspirone, omeprazole and escitalopram. The patient previously took zithromycin and experienced stomach cramps. The patient also took amoxicillin, and experienced drug allergy. The patient received first dose of BNT162B2 on 16Mar2021 at 12:45 (lot number: EN6202, Location: left arm) for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 06Apr2021 at 12:00, the patient experienced muscle pain, joint pain, nausea, headache, weakness, fatigue, injection site pain, flu like aches and pains. No therapeutic measures were taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office, or clinic visit and emergency room or department or urgent care. The outcome of all the events were resolved on Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: BUSPIRONE; OMEPRAZOLE; ESCITALOPRAM

Current Illness:

ID: 1823944
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Hives; Swollen lymph nodes in neck; Rash on legs; This is a spontaneous report from a non-contactable consumer, the patient. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 26Feb2021 at 16:00 (at the age of 71-years-old) as dose 1, single for COVID-19 immunization. Medical history included Chronic Obstructive Pulmonary Disease (COPD), asthma with many allergies and fibro. The patient was allergic to gatorade. Concomitant medications included valaciclovir hydrochloride (VALTREX), duloxetine hydrochloride (CYMBALTA), montelukast sodium (MONTELUKAST), esomeprazole magnesium (NEXIUM) and pravastatin sodium (PRAVASTATIN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received sulfur and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Feb2021, the patient experienced hives, swollen lymph nodes in neck and rash on legs. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events hives, swollen lymph nodes in neck and rash on legs resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: VALTREX; CYMBALTA; MONTELUKAST; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; PRAVASTATIN

Current Illness:

ID: 1823945
Sex: F
Age:
State: NH

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Lightheadedness; headache for more than two days; Nausea; fever for two days; Chills; Exhaustion; Muscle pain; Upset stomach; Injection site throbbing; All over body pain; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EW0150) via an unspecified route of administration in the right arm on 06Apr2021 at 08:30 (at the age of 67-years-old) as a dose 2, single for COVID-19 immunisation. Medical history included diabetic, chronic obstructive pulmonary disease, obesity, depression, and hypertension pulmonary (pulmonary hypertension). Concomitant medications taken within two weeks prior to vaccination included sertraline hydrochloride (ZOLOFT), gabapentin, diltiazem, bupropion and unspecified medication all from unknown date for unknown indication. The patient previously took DEMEROL and experienced drug allergy in the form of itching, also received statin drugs and experienced allergy as severe muscle pain. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection Lot Number: EN6202) via an unspecified route of administration in the right arm on 13Mar2021 at 13:30 (at the age of 67-years-old) as a dose 1, single for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 09:30, the patient experienced light headedness, headache for more than two days, nausea, fever for two days, chills, exhaustion, muscle pain, upset stomach, injection site throbbing and all over body pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event headache was recovered after for more than two days on an unknown date in Apr2021, of fever was recovered after two days on 08Apr2021 and of light headedness, nausea, chills, exhaustion, muscle pain, upset stomach, injection site throbbing, all over body pain were resolving at the time of this report. No follow-up attempts were needed. No further information was expected.

Other Meds: ZOLOFT; GABAPENTIN; DILTIAZEM; BUPROPION

Current Illness:

ID: 1823946
Sex: M
Age:
State:

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: fever; Head aches; anxiety; arm sore; nausea; This is a spontaneous report from a non-contactable consumer (patient) or other non hcp. A 25-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: En6198) via an unspecified route of administration, administered in Arm Left on 26Feb2021 17:30 (at the age of 25-years-old) as dose 1, single for COVID-19 immunization. Medical history included colitis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. No COVID prior to the vaccination. No COVID tested post vaccination. Not diagnosed with COVID-19 since the vaccination. On 26Feb2021, the patient experienced fever, headache, anxiety, arm sore and nausea. No treatment was given for adverse events. The outcome of the events was recovered on an unspecified date in 2021. No follow-up attempts were possible. No further information was expected.

Other Meds:

Current Illness:

ID: 1823947
Sex: M
Age:
State: PA

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:97.8; Test Date: 20210325; Test Name: Body temperature; Result Unstructured Data: Test Result:102.5

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Body temperature 102.5; Chills; Weakness; Nausea (no vomiting); Eyesight difficulty (unable to focus); Pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown) via an unspecified route of administration in the arm left on 24Mar2021 at 16:30 (age at vaccination was 66-year-old) as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history included diabetes, liver problems and high triglycerides from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medications included gabapentin, atorvastatin and fenofibrate. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown) (age at vaccination was 66-year-old) via an unspecified route of administration in the arm left on 03Mar2021 at 16:30 as DOSE 1, SINGLE for COVID-19 immunisation and experienced pain at injection site. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 12:00, the patient experienced peaked body temperature approximately 8 hours after vaccine at 102.5 (units unknown), chills, weakness, nausea (no vomiting), eyesight difficulty (unable to focus) and pain at injection site. Therapeutic measures were not taken as a result of these events. On an unknown date, body temperature was 97.8 (units unknown). The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of the events was recovered in 2021. No follow-up attempts are needed. Information about lot number cannot be obtained.

Other Meds: GABAPENTIN; ATORVASTATIN; FENOFIBRATE

Current Illness:

ID: 1823948
Sex: F
Age:
State: WA

Vax Date: 03/12/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:101 Units:[degF]; Comments: 101deg F

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fever of 101f for 11 days along with body ache,; First dose she had a fever of 101f for 11 days along with body ache, site of injection pain, and mild nausea; Site of injection pain; Mild nausea; This is a spontaneous report from a contactable healthcare professional. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number was not reported) via intramuscular route of administration in the left arm on 12Mar2021 14:00 (at the age of 71-years-old) as dose 1, single for COVID-19 immunization. The patient medical history included hypothyroidism, arteriosclerosis, arthritis, migraine and ischemic brain disease from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient had no known allergies. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unspecified date, the patient experienced fever of 101f for 11 days along with body ache, site of injection pain and mild nausea. No therapeutic measures were taken as a result of these events. The clinical outcome of the event fever was recovered on an unspecified date and rest events outcome was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) :-PFIZER INC-2021391438 similar report from same reporter

Other Meds:

Current Illness:

ID: 1823949
Sex: F
Age:
State: WA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: second dose began with 5 days of chills body ache, decreased appetite; second dose began with 5 days of chills body ache, decreased appetite; body ache; runny nose; persistent cough; This is a spontaneous report from a contactable other health care professional. A 71-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRna vaccine, solution for injection), dose 2 intramuscular, administered in Arm Left on 02Apr2021 14:00 (at the age of 71-Years-old) (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included hypothyroidism, arteriosclerosis, arthritis, migraine and ischemic brain disease. Concomitant medication included warfarin sodium (COUMADIN) taken for an unspecified indication, lamotrigine (LAMICTAL) taken for an unspecified indication, levothyroxine taken for an unspecified indication, omeprazole magnesium (PRILOSEC) taken for an unspecified indication, furosemide taken for an unspecified indication and atorvastatin calcium (ATORVASTIN) taken for an unspecified indication. Patient did not receive other vaccine in four weeks. Patient did not had covid prior to vaccination. Patient was not tested for covid-19 post vaccination. No known allergies were reported. The patient was not pregnant at the time of vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRna vaccine, solution for injection), dose 1 intramuscular, administered in Arm right on 12Mar2021 14:00 (at the age of 71-Years-old) (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation and experienced Fever, body ache, site of injection pain and mild nausea. On 02Apr2021 19:00, the patient after second dose began with 5 days of chills body ache, decreased appetite, runny nose, persistent cough. Therapeutic measures were not taken with respect to event. At the time of this report, the outcome of events chills body ache, decreased appetite was recovered with sequel on 07Apr2021 and other events recovered with sequel on an unknown date in 2021. The lot number for the vaccine,(Pfizer/BioNTech COVID-19 vaccine), was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021391423 similar report from same reporter

Other Meds: COUMADIN; LAMICTAL; LEVOTHYROXINE; PRILOSEC; FUROSEMIDE; ATORVASTIN

Current Illness:

ID: 1823950
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: burning up all day; pain in her hip and it went to her toes; pain in her hip and it went to her toes; Nausea; This is a spontaneous report from a non-contactable consumer (patient). A 90-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 90-year-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced burning up all day, pain in her hip and it went to her toes (One night), nausea and by the time she got a bowl it was gone. The outcomes of events were unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1823951
Sex: M
Age:
State: AZ

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: hands swelled up; hand and wrist joints got sore beyond what caused by osteoarthritis; hand and wrist joints got sore beyond what caused by osteoarthritis; lost strength in fingers; This is a spontaneous report from a contactable consumer (patient). A 71-years-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 27Feb2021 (at age of 71-years-old) 20:00 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included not sure this is shot-related; may be reaction to blood pressure meds on unknown date and unknown if ongoing. Concomitant medications were not known (reported as quite a few). The patient had known allergies to morphine. The patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Left shoulder on 21Mar2021 (Batch/Lot Number: ER2613) as DOSE 2, SINGLE for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 27Feb2021, the patient experienced hands swelled up, hand and wrist joints got sore beyond what caused by osteoarthritis and lost strength in fingers. The patient received treatment for adverse event as steroid shot. The outcome of events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823952
Sex: F
Age:
State: WI

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID-19 virus test; Test Result: Negative

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: off tasting of food; Dizziness; Exhaustion; Body aches; This is a spontaneous report from a contactable consumer, the patient. This is the second of two reports. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm right on 08Apr2021 at 15:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatism, vitiligo and allergy to "many and many things" and a coworker tested positive for COVID from an unknown date and unknown if ongoing. Concomitant medications included paracetamol (ACETAMINOPHEN), ubidecarenone (COENZYME Q10) and calcium (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and stop date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 11Mar2021 at 15:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation and experienced nausea and dizziness. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 10:30, the patient experienced all foods and beverages taste 'off'/off tasting of food. Sweet foods and beverages were so much sweeter that they were not even comfortable to eat. Savory foods and beverages were quite bitter. It made her not want to eat anything. The patient inquired that how long would this weird taste continue. After the second dose, the patient also had dizziness, exhaustion and body aches. The patient previously never experienced COVID symptoms but was tested months ago on unknown date after a coworker tested positive for COVID and the result came back negative. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events off tasting of food, dizziness, exhaustion and body aches was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ACETAMINOPHEN; COENZYME Q10 [UBIDECARENONE]; CALCIUM

Current Illness:

ID: 1823953
Sex: F
Age:
State: PA

Vax Date: 03/16/2021
Onset Date: 03/19/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: This is a spontaneous report from a contactable consumer or other non hcp. A 51-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 16Mar2021 18:30 (Batch/Lot Number: EN6204) (at the age of 51-years-old) as dose 1, single for covid-19 immunisation. There was no medical history reported. The patient's concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient had received no other medications in two weeks. The patient had not covid-19, prior vaccination. The patient had not been tested covid-19, post vaccination. The patient experienced headaches for about 3 days on 19Mar2021 06:00 and on the same date patient experienced joint aches: not able to wear wedding ring for about 5 days. The clinical outcome if the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823954
Sex: F
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Sore arm; Swelling of my lymph nodes by my collarbone/neck on injection site side only; Tired; Weakness; A slight sporadic vibration in my lip on the right side that disappeared afer a week; Shoulder area is sore feeling muscle tightness down right upper arm (near injection site) muscle/shoulder blade area & up right side of neck.; Muscle tightness; Shoulder area is sore feeling muscle tightness down right upper arm (near injection site) muscle/shoulder blade area & up right side of neck.; This is a spontaneous report from a contactable consumer (patient). A 62-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in Arm Right on 25Mar2021 (at the age of 62-year-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included zinc (ZINC); fish oil (FISH OIL); ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). No allergies reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: EN6203) via an unspecified route of administration at Arm Right on 04Mar2021 11:15 (at the age of 62-year-old) as dose 1, single for covid-19 immunisation and reported sore arm and bruising for about a week. Facility where the most recent COVID-19 vaccine was administered reported as pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 the patient experienced really sore arm and swelling of my lymph nodes by my collarbone/neck on injection site side only. Incredibly tired for two weeks with some weakness. A slight sporadic vibration in my lip on the right side that disappeared after a week. Though today is 2 weeks after 2nd dose and swelling of lymph nodes is still visible/tender & tightness near collarbone. Shoulder area is sore feeling muscle tightness down right upper arm (near injection site) muscle/shoulder blade area & up right side of neck. Reporter assessed case as non-serious. Patient did not receive any treatment for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of event A slight sporadic vibration in my lip on the right side that disappeared after a week was recovered on 2021 and rest all was not recovered. No follow-up attempts are needed. No further information is expected. Sender's Comments: Linked Report(s) : US-PFIZER INC-2021385684 Same patient, same product with different dose, partial same event

Other Meds: ZINC; FISH OIL; VITAMIN D [ERGOCALCIFEROL.]

Current Illness:

ID: 1823955
Sex: M
Age:
State: ID

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: fever; cold sweats; body aches; migraine; fatigue; This is a spontaneous report from a contactable consumer (Patient). A 32-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown, Expiry date: Unknown) via an unspecified route of administration, administered in Arm Right on 03Apr2021 at 11:45 (age at vaccination: 32 year-old) as dose 2, single for COVID-19 immunization. Medical history and concomitant medications were reported as none. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 13Mar2021 at 00:00 (at the age of 32-year-old) as dose 1, single for COVID-19 immunization and experienced minor chills and body aches. Allergies to medications, food, or other products were reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 04:00, the patient experienced fever, cold sweats, body aches, migraine and fatigue the first and third day after vaccination. No treatment received for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of events was recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823956
Sex: F
Age:
State: NY

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: pain at injection site (for 1-3 days)/Pain during injection of second dose; More fatigue; Some stomach discomfort; Flushing- redness of face; This is a spontaneous report from a non-contactable consumer (Patient). A 68-years-old (non-pregnant) female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: Unknown) 07Apr2021 at 14:45 via an unspecified route of administration in the left arm as DOSE 2, SINGLE for COVID-19 immunisation (age at vaccination:68-years-old). The patient medical history included unspecified allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination.Previously the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: Unknown), via an unspecified route of administration in the left arm on 10Mar2021 at 15:15 as DOSE 1, SINGLE for COVID-19 immunisation. After the first dose, the patient experienced pain at injection site (pain at site for 1-3 days), slight swelling at injection site and fatigue. The patient concomitant medications included levothyroxine sodium (SYNTHROID), rosuvastatin and ibuprofen since an unspecified date for unknown indications. On 07Apr2021, the patient experienced pain during injection of second dose, flushing-redness of face. The patient also experienced pain at injection site (for 1-3 days), fatigue, some stomach discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events flushing-redness of face, more fatigue and "some stomach discomfort" was unknown. The outcome of the event pain at injection site (for 1-3 days)/Pain during injection of second dose was resolved on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: SYNTHROID; ROSUVASTATIN; IBUPROFEN.

Current Illness:

ID: 1823957
Sex: F
Age:
State: TN

Vax Date: 03/05/2021
Onset Date: 03/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: had my period for almost 5 weeks straight; heavier bleeding than usual; Much stronger cramps; It also lasted 7 days with light bleeding for several more days. There were about 2 days with no bleeding and then I started another menstrual cycle; This is a spontaneous report from a contactable consumer (Patient). A 30-years-old non-pregnant female patient received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6200), dose 1 via an unspecified route of administration, administered in Arm Right on 05Mar2021 12:45 PM as DOSE 1, SINGLE for covid-19 immunisation (at the age of 30 years). Medical history included polycystic ovaries from an unknown date and unknown if ongoing. No known allergies and other medical history. The patient's concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient did not received other vaccine in four weeks. No covid prior vaccination and also no covid tested post vaccination. The patient experienced on 08Mar2021 she have had her period for almost 5 weeks straight. The patient first started her menstrual cycle about 3 days after the first vaccine. She didn't think much about it, but it did not feel normal. Much stronger cramps and heavier bleeding than usual. It also lasted 7 days with light bleeding for several more days. There were about 2 days with no bleeding and then she started another menstrual cycle. This time it felt similar to her usual periods. The patient then got her 2nd vaccine and had very light bleeding for about a week and a half. She have now started another period and this one seems to be similar to the one she had after the first dose. The patient should note that she have never had periods for this long or this frequent. She have PCOS so her body is used to not having them for months. Even after going a year without one while pregnant and nursing, it still only lasted 5 days she had no other symptoms other than a slightly sore arm at the injection site. The patient did not received any treatment for the events. The clinical outcome of all the events were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823958
Sex: F
Age:
State: KS

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Rash resembles contact dermatitis; mild pruritis; Papular rash noted on left arm/rash has spread to encompass arm - mainly inside of arm (adjacent to main vasculature); This is a spontaneous report from a contactable other healthcare professional (regarding a patient). A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) (age at the time of vaccination was 37 years, patient was non-pregnant at the time of vaccination), via an unspecified route of administration in the left arm on 09Apr2021 at 16:00 (at the age of 37-year-old) as a dose 2, single for COVID-19 immunization. Concomitant medications included venlafaxine (VENLAFAXINE) and numerous supplements recommended by primary care provider from unknown date for unspecified indications. The patient previously received morphine injections and experienced adverse cutaneous reaction. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206) via an unspecified route of administration in the left arm on 12Mar2021 at 16:00 (at the age of 37-year-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 18:00 the patient experienced papular rash on left arm approximately two hours after vaccination, seemed to coincide with the flush side effect of onset on niacin 1000mg supplementation. 18hours post vaccination, rash has spread to encompass arm mainly inside of arm adjacent to main vasculature. The rash resembled contact dermatitis with mild pruritus. The patient didn't visited physician or other health professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with self administered diphenhydramine. The outcome of the events was not recovered at the time of this report. No follow-up attempts were needed. No further information was expected.

Other Meds: VENLAFAXINE

Current Illness:

ID: 1823959
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 24-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 24, via an unspecified route of administration, on an unknown date, for COVID-19 immunisation. Medical history and concomitant medication not reported. The patient previously took the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), via an unspecified route of administration, on an unknown date, single dose, for COVID-19 immunization; and experienced sore arm. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. On an unknown date, patient experienced extremely sore arm, heavy body, fatigue, chills and minor fever. The events did not result in doctor or other healthcare professional office/clinic visit/emergency room/department or urgent care. The outcome of extremely sore arm, fatigued, heavy body, chills and minor fever: unknown (at the time of this report). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1823960
Sex: F
Age:
State: FL

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:allergy; Comments: allergy verified by blood test.

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: significant shoulder/neck stiffness; headache; raised red rash on stomach and chest, not really itchy/Rash still here am; raised red rash on stomach and chest, not really itchy; muscle soreness and headache back to mild; raised red rash on stomach and chest, not really itchy/Rash still here am; This is a spontaneous report from a contactable other hcp (Nurse) (patient). A 48-year-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in arm left on 06Apr2021 08:45 (at the age of 48-year-old) at dose 2, single for covid-19 immunisation. Medical history included hypothyroid and allergies to sesame seeds, severe abd pain, allergy verified by blood test, chia seeds anaphylaxis. Latex rash and allergy verified by blood test. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included levothyroxine (LEVOTHY-ROXINE); lysine (LYSINE); vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]); vitamins nos (MULTIVITAMIN [VITAMINS NOS]), all taken for an unspecified indication, start and stop date were not reported, patient received these medications within 2 weeks of vaccination. Patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6200) via an unspecified route of administration, administered in arm left on 16Mar2021 08:45 (at the age of 48-year-old) at dose 1, single for covid-19 immunisation after 1st dose patient experienced mild shoulder/neck stiffness, arm sore, not bad. On 07Apr2021 19:00 the patient experienced adverse event after 2nd dose significant shoulder/neck stiffness, headache and eve of 4/7 raised red rash on stomach and chest, not really itchy. Rash still here am of 4/8/21 but muscle soreness and headache back to mild. The patient underwent lab tests and procedures which included blood test: allergy on an unspecified date (allergy verified by blood test). Patient did not received treatment for the adverse events. Outcome of the events was resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; LYSINE; VITAMIN D [VITAMIN D NOS]; MULTIVITAMIN [VITAMINS NOS.]

Current Illness:

ID: 1823961
Sex: F
Age:
State: WI

Vax Date: 03/12/2021
Onset Date: 04/03/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210403; Test Name: Body temperature; Result Unstructured Data: Test Result:100 degrees

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: 100 degree temp; swollen lymph nodes under arm; This is a spontaneous report from a contactable other health care professional (patient herself). A 47-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Not reported, Expiration date: Unknown), via an unspecified route of administration on 12Mar2021 at 12:15 as dose 1, single (at the age of 47-years-old) for COVID-19 immunisation. The patient also received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: 59267-1000-01, Expiration date: Unknown), via an unspecified route of administration on 09Apr2021 at 12:15 as dose 2, single for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included blood pressure abnormal, allergy to cephalosporins and ob/gynae issues (gynaecological examination abnormal) from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's concomitant medications included iron, vaccinium macrocarpon (CRANBERRY), vitamin D, birth and blood pressure medications taken for an unspecified indication, start and stop date were not reported. On 03Apr2021 at 12:30, the patient experienced 100 degree temp and swollen lymph nodes under arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient underwent lab tests and procedures which included body temperature: 100 degrees on 03Apr2021. Therapeutic measures were not taken as a result of the events. The outcome of the events was recovering. No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.

Other Meds: IRON; CRANBERRY

Current Illness:

ID: 1823962
Sex: F
Age:
State: LA

Vax Date: 12/26/2020
Onset Date: 12/26/2020
Rec V Date: 10/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 202003; Test Name: COVID-19; Result Unstructured Data: Test Result:positive; Test Date: 202101; Test Name: COVID-19; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab; Test Date: 202102; Test Name: COVID-19; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: depression; mania; I had to go to bed; Vaccination hurt going in and I could feel it in my arm; light headed/Dizzy; weak; nausea; chills; body aches; low grade fever; extreme fatigue; anxious; This is a spontaneous report received from a contactable other HCP (nurse) (patient). A 70-year-old non-pregnant female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EH9899), via an unspecified route of administration in the left arm on 26Dec2020 (at the age of 70-year-old), as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient medical history included fibromyalgia, ADHD (Attention deficit hyperactivity disorder), hypertension, asthma and COVID-19 on an unspecified date in Mar2021 and patient still have no smell or taste. Concomitant medications were not reported. the patient previously took Macrobid and experienced allergy. Prior vaccinations within four weeks were reported as none. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 26Dec2020, the patient experienced vaccination hurt going in and she could feel it in her arm, within 1 hour she started getting lightheaded, weak and dizzy, she had to go to bed. On 26Dec2021, the patient reported that she had nausea, chills, body aches, low grade fever and then extreme fatigue which lasted for 2 days, light fatigue and nausea for 4 days, she was anxious and then one morning fell into a deep, deep depression the next week, after about 4 hrs it turned into mania. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on Mar2020, negative; Nasal Swab on Jan2021 and Feb2021. Adverse events did not require Emergency room/Physician office visit. The patient did not receive any treatment for the events. The outcome of the events (extreme fatigue, depression) was not recovered, events (Vaccination hurt going in and I could feel it in my arm, lightheaded/Dizzy, weak, chills, body aches, low grade fever) was recovered on 28Dec2020, event (nausea) was recovered on 30Dec2020, and event (anxiety, mania) was recovered on an unknown date. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823963
Sex: F
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210409; Test Name: Pulse rate; Result Unstructured Data: Test Result:115-120; Comments: Elevated, 115-120 bpm

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: difficulty breathing/shortness of breath; About 3 hours after receiving the shot, I started having sharp chest pain.; pulse rate was very elevated. About 115-120 bpm; tightness in my chest; This is a spontaneous report from a contactable consumer (patient). A 24-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: ER8729, Expiry date: not reported), via an unspecified route of administration in left arm on 09Apr2021 13:45 (at age of 24-years-old) as dose 1, single for COVID-19 immunization in pharmacy or drug store. The patient was not pregnant at the time of vaccination. Medical history included leukopenia, eczema and allergies to nitrates. Concomitant medication(s) included apple cider vinegar (APPLE CIDER VINEGAR) taken for an unspecified indication, start and stop date were not reported; Birth control and black elderberry taken for an unspecified indication, start and stop date were not reported. The patient previously took augmentin [amoxicillin;clavulanic acid] and experienced allergy. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The reporter stated that on 09Apr2021 at 16:45, about 3 hours after receiving the shot, I started having sharp chest pain, pulse rate was very elevated. About 115-120bpm. About an hour after that, I began to have tightness in my chest and difficulty breathing/shortness of breath. The events were assessed as non-serious. The patient underwent lab tests and procedures which included heart rate: on 09Apr2021 Elevated, 115-120 bpm. No therapeutic measures were taken in response to the events. It was reported that (all of those symptoms remained for the next 24 hours. The events recovered on an unspecified date in Apr2021. ~ No follow-up attempts are needed. No further information is expected.

Other Meds: APPLE CIDER VINEGAR

Current Illness:

ID: 1823964
Sex: F
Age:
State: PA

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:100 Fahrenheit

Allergies:

Symptom List: Unevaluable event

Symptoms: Severe soreness of arm where injected (could not lift arm up for several hours); Mild fever (100F); This is a spontaneous report from a contactable consumer (herself). This is first of two reports. A 51-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EP8734) via an unspecified route of administration, administered on Arm Right on 17Mar2021 at 10:15 as a DOSE 1, SINGLE for COVID-19 immunisation (at the age of 51 years). Medical history included in 2019 ongoing breast cancer (Breast cancer- dx 2019, ongoing treatment with aromatase inhibitor) and on unknown date COVID-19. Concomitant medications included anastrozole (ARIMIDEX) and calcium carbonate, vitamin d nos (CALCIUM + VIT D). The patient previously took ciprofloxacin antibiotic and experienced drug allergy on an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in Mar2021, the patient experienced severe soreness of arm where injected and mild fever of 100F. Therapeutic measures were not taken as a result of these events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date, the patient underwent body temperature test and the result was 100 F. The clinical outcome of the events severe soreness of arm where injected and mild fever of 100F was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ARIMIDEX; CALCIUM + VIT D

Current Illness: Breast cancer (Breast cancer- dx 2019, ongoing treatment with aromatase inhibitor)

ID: 1823965
Sex: F
Age:
State: TN

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Chills; Fever; Nausea; Fatigue; Extreme muscle pain all over body; Extreme joint pain all over to include hands; Severe headache.; This is a spontaneous report from a non-contactable other healthcare professional (patient). This is the second of two reports. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EW0151) via an unspecified route of administration in the right arm on 06Apr2021 at 13:30 (at the age of 38-years-old and non-pregnant at the time of vaccination) as DOSE 2, SINGLE for COVID-19 immunisation. The medical history included asthma. The patient had known allergies included tree nut allergy. Concomitant medications included ascorbic acid (VITAMIN C), vitamin D (VITAMIN D NOS), melatonin, ibuprofen and paracetamol (TYLENOL). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6204) via an unspecified route of administration in the right arm in Mar2021 at 13:30 (at the age of 38-years-old) as DOSE 1, SINGLE for COVID-19 immunisation and experienced soreness at the injection site. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. After the 2nd dose of the Pfizer Vaccine, on 07Apr2021 at 01:30, approximately 12 hours after the injection the patient experienced chills, fever, nausea, fatigue, extreme muscle pain all over body, extreme joint pain all over to include hands, and severe headache. The aforementioned effects lasted about 36 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The outcome of the events was recovered on 08Apr2021 at 13:30. No follow-up attempts are possible. No further information was expected.

Other Meds: VITAMIN C; VITAMIN D NOS; MELATONIN; IBUPROFEN; TYLENOL

Current Illness:

ID: 1823966
Sex: F
Age:
State: UT

Vax Date: 03/16/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin; having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin; Having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin; Having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin.; Having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin.; Having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin.; Having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin.; Having painful swollen glands and lymph nodes under my right arm, in my neck, shoulders, breasts, pelvis and groin; Impossible to sleep; Felt fatigued and miserable; Felt fatigued and miserable; Swelling in my face and neck, knees and ankles; Swelling in my face and neck, knees and ankles; Migraines from the pressure in my face and neck; My food and drink had a metallic taste to it; This is a spontaneous report from a contactable consume (patient). A 53-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration, administered in right arm on 16Mar2021 14:15 (age at the time of vaccination was 53-year-old) as dose 1, single for COVID-19 immunisation. The patient's medical history included migraine, fibromyalgia and chronic pain from being in a coma as a child due to being hit by a car as a pedestrian. Concomitant medications included galcanezumab (EMGALITY [GALCANEZUMAB]), sumatriptan succinate (IMITREX), tapentadol hydrochloride (NUCYNTA), butalbital and ibuprofen. The patient previously took codeine and experienced known drug allergy. Patient was not pregnant at time of vaccination. Patient had not received any other vaccine within 4 weeks. Patient had not been tested for COVID-19 since the vaccination. The patient reported that within a day or two in Mar2021, he started having painful swollen glands and lymph nodes under his right arm, neck, shoulders, breasts, pelvis and groin. They have been so painful it was next to impossible to sleep due to the pressure from lying down on them. The patient felt fatigued and miserable. He also experienced swelling in his face and neck, knees and ankles. The pain from these had been miserable. He also experienced migraines from the pressure in his face and neck. For two days, his food and drink had a metallic taste to it, overall, it has been a miserable experience, which was sad, because he was not nervous about getting the vaccine in the least. The patient did not think I can risk going through this again, it was way too taxing to my system. I ended up in the ER on Sunday as his face was so swollen and the pain was too much. The patient was not received any treatment for the events. Outcome of the events was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: EMGALITY [GALCANEZUMAB]; IMITREX; NUCYNTA; BUTALBITAL; IBUPROFEN

Current Illness:

ID: 1823967
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: severe chills; fever; all over body aches; shooting pain in joints and back of head; headache/shooting pain in back of head; shortness of breath; general malaise; This is a spontaneous report from a contactable consumer (patient). This 34-year-old female patient (non pregnant) received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: Ew0153) on 09Apr2021at 10:30 via an unspecified route of administration in the left arm as DOSE 2, SINGLE for COVID-19 immunisation (age at vaccination:34-years-old). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient did not have Covid prior vaccination neither covid tested post vaccination. The patient's other medical history included: OCD, and complex PTSD. Patient reported known allergy to Nickel. Patient took Celexa and lorazepam within 2 weeks of vaccination. Previously the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: En6207) on 19Mar2021at 10:15 via an unspecified route of administration in the left arm as DOSE 1, SINGLE for COVID-19 immunisation. Patient did not have any past drug history.On 09Apr2021, at 22:00 the patient experienced severe chills, fever, all over body aches, shooting pain in joints and back of head, headache, shortness of breath, and general malaise. Patient did not receive any treatment for the events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: CELEXA [CELECOXIB]; LORAZEPAM

Current Illness:

ID: 1823968
Sex: M
Age:
State: IL

Vax Date: 02/17/2021
Onset Date: 02/19/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: 2 days after the 1st shot upper body, arms, and thighs developed itchy rashes/hives.; A number of tiny blood red dots on skin; 2 days after the 1st shot upper body, arms, and thighs developed itchy rashes/hives.; skin inflammation; The rashes slowly faded, but left a few dark color skin marks; This is a spontaneous report from a contactable consumer, the patient. This is first of two reports. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Feb2021 at 10:30 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Patient had no medical history and had no known allergy to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 19Feb2021 at 12:00, 2 days after the 1st shot, the patient experienced upper body, arms, and thighs developed itchy rashes/hives and a number of tiny blood red dots on the patient's skin. The rashes slowly faded, but left a few dark color skin marks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with antihistamine Allegra D, but it wasn't effective and 10 days later he saw his doctor and was prescribed triamcinolone acetonide cream, which helped to calm the patient's skin inflammation. The clinical outcome of the events upper body, arms, and thighs developed itchy rashes/hives and a number of tiny blood red dots on the patient's skin was recovered with sequelae on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1823969
Sex: F
Age:
State: MI

Vax Date: 03/19/2021
Onset Date: 03/12/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:102.4.

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: 3/19 (2nd first shot) - chills and feverup to 102.4 before taking tylenol -fever gone w/in 24 hours - body achescontinued for another 24 hrs (backpain); 3/19 (2nd first shot) - chills and feverup to 102.4 before taking tylenol -fever gone w/in 24 hours - body achescontinued for another 24 hrs (backpain); 3/19 (2nd first shot) - chills and feverup to 102.4 before taking tylenol -fever gone w/in 24 hours - body achescontinued for another 24 hrs (backpain); Back pain; none after first shot on 12Mar" (refrigeration issue - had to have first shot again on 19Mar; none after first shot on 12Mar" (refrigeration issue - had to have first shot again on 19Mar; none after first shot on 12Mar" (refrigeration issue - had to have first shot again on 19Mar; This is a spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 09:30 (at the age of 55-year-old and non-pregnant at the time of vaccination) as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history included pre-diabetic and high blood pressure. The patient had no known allergies. Concomitant medications included losartan and metformin. It was reported that the patient had received other vaccines within four weeks prior to the vaccination. The patient also received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6205) via an unspecified route of administration in the left arm on 12Mar2021 (at the age of 55-year-old and non-pregnant at the time of vaccination) as DOSE 1, SINGLE for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported by the patient that "none after first shot on 12Mar" (refrigeration issue - had to have first shot again on 19Mar). On 19Mar2021 (after second shot), the patient experienced chills and fever up to 102.4 before taking TYLENOL. The event fever gone within 24 hours body aches continued for another 24 hours (back pain). Therapeutic measures were taken as a result of the events and included treatment with TYLENOL. The outcome of the event fever up to 102.4 was recovered in 2021, however the chills, body aches and back pain was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; METFORMIN.

Current Illness:

ID: 1823970
Sex: F
Age:
State:

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Approximately 8 hours after receiving the first dose, my torso, arms, neck, and face began to itch; My hands were swollen; This is a spontaneous report from a non-contactable consumer (patient). A 38-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Batch/Lot number: Not reported), via an unspecified route of administration, administered in Arm Left on 20Mar2021 09:00 (at the age of 38 years-old) as single dose for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing Known allergies: Sulfur of all types in medications, foods, health and beauty products, etc, food allergy from an unknown date and unknown if ongoing. Concomitant medication(s) included calcium, vitamin d, flonase, Zyrtec taken for an unspecified indication, start and stop date were not reported. On 20Mar2021, the patient experienced approximately 8 hours after receiving the first dose, my torso, arms, neck, and face began to itch, my hands were swollen. Therapeutic measures were taken as a result of approximately 8 hours after receiving the first dose, my torso, arms, neck, and face began to itch, my hands were swollen included treatment with benadryl. The clinical outcome of the events my torso, arms, neck, and face began to itch, My hands were swollen was recovered/resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CALCIUM; VITAMIN D; FLONASE [FLUTICASONE PROPIONATE]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1823971
Sex: F
Age:
State: TX

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210402; Test Name: Fever; Result Unstructured Data: Test Result:105.5; Test Date: 20210402; Test Name: Fever; Result Unstructured Data: Test Result:102.8; Test Date: 20210402; Test Name: Fever; Result Unstructured Data: Test Result:103.8

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: still tired; 2nd shot: fri woke in horrible pain all joints and muscles; 2nd shot: fri woke in horrible pain all joints and muscles; Barley walk; chills; beginning of fever; brain fog; This is a spontaneous report from a contactable consumer (patient). A 48-year-old-female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EP6955 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 01Apr2021 at 04:30 PM (age at vaccination: 48 years), as dose 2, single dose for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included tachycardia, iron deficiency anemia, and known allergies: Omitted. Concomitant medications included motropolol, acetylsalicylic acid (BABY ASPRIN), curcuma longa (TURMERIC), magnesium, and vita. Past drug included amoxicillin and had known allergies: amoxicillin. Historical vaccine included first dose of BNT162B2 (PFIZ-ER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6199 and expiry date was not reported), via an unspecified route of administration, in Arm Right, on 11Mar2021 at 01:30 PM, as dose 1, single dose for COVID-19 immunization at hospital and had breast pain right breast for days. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 02Apr2021, the patient had 2nd shot: fri woke in horrible pain all joints and muscles. Barley walk. By 2:30, chills and beginning of fever. By 5pm, she had 105.5 fever while on Motrin. Fever bt 102.8 and 103.8 through the night while alternating tylonal and Motrin every 3 hours. Saturday no fever, brain fog, exhaustion. Sunday still tired and muscle weakness. Monday still not feeling really gut- no energy. Now it was Friday, day 8 and still feel off with throat/ breath. She could breathe deeply, but slight cough and tightness at base of throat. The patient did not receive any treatment for the events. Outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL; BABY ASPIRIN; TURMERIC [CURCUMA LONGA]; MAGNESIUM

Current Illness:

ID: 1823972
Sex: U
Age:
State: PA

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Covid testing; Test Result: Negative

Allergies:

Symptom List: Nausea

Symptoms: loss of smell and taste; loss of smell and taste; fatigue; body aches; chills; headache; backache; This is a spontaneous report from a contactable consumer (patient) forwarded as an Adverse Event by the team on 09Apr2021. A patient of unspecified age and gender received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: not reported), via an unspecified route of administration on 27Mar2021 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included non-small cell lung cancer. Concomitant medications included keytruda taken for non-small cell lung cancer on an unspecified date. Previously patient took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date for covid-19 immunisation. The patient experienced chills, headache and backache on 28Mar2021, fatigue and body aches on 29Mar2021, loss of smell and taste on 30Mar2021. The clinical course reported as follows, it was reported that patient received the Pfizer second vaccine on 27Mar2021. The next day experienced chills and a headache and backache. Two days later fatigue and body aches. The third day loss of smell and taste. All days afebrile. Negative Covid testing as well. Taste and smell are not back over 9 days. Patient was on Keytruda for non-small cell lung cancer every six weeks. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on unspecified date. The clinical outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: KEYTRUDA

Current Illness:

ID: 1823973
Sex: M
Age:
State: WV

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Pain in joints; This is a spontaneous report from a contactable consumer, the patient. This is the first of two reports. A 76-year-old male patient received the first dose of BNT162b2 (Pfizer BioNTech Covid-19 mrna vaccine; Lot number: EN6198) via an unspecified route of administration in the left arm on 26Feb2021 at 13:00 (at the age of vaccination 76-year-old) as a dose 1, single for COVID-19 immunisation. Medical history included Crohn's disease, acid reflux, sluggish artery, and heart disease-stent. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had taken other medications (unspecified) within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took atorvastatin on an unknown date for unknown indication and experienced drug allergy. Since the vaccination, the patient had not been tested for COVID-19. On 27Feb2021 at 11:00, the patient experienced pain in joints that were normal. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pain in joints which included treatment with meloxicam (MOBIC). The clinical outcome of the event pain in joints was unknown at the time of this report. No follow-up attempts are needed. No further information was expected.

Other Meds:

Current Illness:

ID: 1823974
Sex: F
Age:
State: NY

Vax Date: 03/24/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: On 02Apr2021, she flared up with asthma (10 days after the second dose); She had flu-like symptoms for 2-3 days and these symptoms and the headache were gone on 28Mar2021; She had flu-like symptoms for 2-3 days and these symptoms and the headache were gone on 28Mar2021; This is a spontaneous report from a contactable pharmacist (patient). A 68-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown, and Expiration date: Unknown), via an unspecified route of administration on 24Mar2021 (at the age of 68-year-old) as dose 2, single for COVID-19 immunization. The patient medical history included Flu in Jan2021 (she had a bad episode of flu (maybe Covid)) and ongoing asthma (in Jan2021, flared up her asthma). Concomitant medication included fluticasone propionate, salmeterol xinafoate (ADVAIR) and salbutamol sulfate (PROAIR [SALBUTAMOL SULFATE]). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown, and Expiration date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. It was reported that, the patient received the second dose of the Pfizer-BioNtech Covid-19 vaccine on 24Mar2021. On an unspecified date in Mar2021, "she had flu-like symptoms for 2-3 days and these symptoms and the headache were gone on 28Mar2021". On 02Apr2021, she flared up with asthma (10 days after the second dose). The patient wanted to know if this had been seen during the clinical trials or reported (anything that affects the immune system). The patient stated she usually takes a low dose of Advair and Proair. Around 03Apr2021 she received Duoneb nebulizer solution as a treatment for flared up asthma. The case was reported as non-serious. The outcome of the events flu like symptoms and headache was reported as resolved on 28Mar2021. The outcome of event "On 02Apr2021, she flared up with asthma (10 days after the second dose)" was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ADVAIR; PROAIR [SALBUTAMOL SULFATE]

Current Illness: Asthma (Verbatim: flared up her asthma)

ID: 1823975
Sex: F
Age:
State: IL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: After the first shot had swelling around eyes; After the first shot i had swelling around my eyes and they were very itchy.; This is a spontaneous report from a contactable consumer (patient) and Other HCP. This is the first of two reports. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0150) via an unspecified route of administration in the arm left on 07Apr2021 at 14:30 (at the age of 23-year-old) at dose 1, single for COVID-19 immunisation. Medical history included syncope, low blood pressure, menstrual issues, environmental allergies and allergic to mushrooms. Concomitant medications included fluoxetine hydrochloride (PROZAC), trazodone (MANUFACTURER UNKNOWN) and birth control, all for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 19:00 after the first shot the patient had swelling around eyes and they were very itchy. The events resulted in emergency room/department visit or urgent care. Patient received treatment with oral steroids for the event swelling around eyes and they were very itchy. The clinical outcome of the event after the first shot had swelling around eyes and they were very itchy was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC; TRAZODONE

Current Illness:

ID: 1823976
Sex: F
Age:
State: GA

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: ultrasound; Result Unstructured Data: Test Result:Doctor ordered ultrasound to be sure it was nothin

Allergies:

Symptom List: Tremor

Symptoms: My throat swelled up like a balloon; This is a spontaneous report from a contactable consumer (patient) and other HCP. A 73-year-old non pregnant female patient received bnt162b2 (BNT162B2, solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in the left arm on an unspecified date (at the age of 73 years old) as dose 2, single for COVID-19 immunisation at hospital. Patient was not pregnant at the of vaccination. Medical history included cardiac and kidney issues, Known allergies: Yes. Patient previously took bnt162b2 (BNT162B2, solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration, administered in the left arm on an unspecified date (at the age of 73 years old) as dose 1, single for COVID-19 immunisation and experienced sore arm, swelling at shot site. Other medications were given within 2 weeks. No other vaccines were given within 4 weeks. On 01Apr2021 12:00, the patient experienced my throat swelled up like a balloon. The patient underwent lab tests and procedures which included ultrasound scan as doctor ordered ultrasound to be sure it was nothing else. Therapeutic measures were taken as a result of my throat swelled up like a balloon and included with treatment 2 different ultrasounds to check thyroid and gland. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. AE resulted to doctor or other healthcare professional office/clinic visit. The clinical outcome of the event was reported as recovering. No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823977
Sex: F
Age:
State:

Vax Date: 04/12/2021
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Shortness of breath while climbing stairs; This is a spontaneous report from a contactable consumer (patient's mother). A 28-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported) via an unspecified route of administration on 12Apr2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Apr2021, the patient experienced shortness of breath while climbing stairs. The outcome of event was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823978
Sex: F
Age:
State: PA

Vax Date: 03/28/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: She said she's generally ill; sore throat; tiredness as well as joint pain after getting the vaccine; tiredness as well as joint pain after getting the vaccine; This is a spontaneous report from contactable consumer (patient) via a Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot/batch number was not reported) via an unspecified route of administration on 28Mar2021 as dose 1, single for covid-19 immunisation. The patients medical history and concomitant medications were not reported. The patient would like to know how long a vaccine recipient could be experiencing side effects. She said she was generally ill. She received the first dose on 28Mar2021, and she had been experiencing sore throat, tiredness as well as joint pain after getting the vaccine. The outcome of events was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1823979
Sex: F
Age:
State: LA

Vax Date: 03/18/2021
Onset Date: 03/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Headache; A few heart palpitations- this was sporadic and did not last long; numbness of left side and marked numbness of left thumb and up left forearm; Strong skin tingling all over body; Knee joints felt like they were on fire; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6204) via an unspecified route of administration in the left arm on 18Mar2021 at 13:00 (at the age of 51-years-old and non-pregnant at the time of vaccination) as a DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications included estradiol and lisinopril. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 18Mar2021, the patient reported that she experienced a headache which started immediately after the first shot. In Mar2021, the patient experienced strong skin tingling all over the body, no fever, her knee joints felt like they were on fire, fatigue, headache, a few heart palpitations that were sporadic and did not last long, numbness of left side and marked numbness of left thumb and up left forearm. The patient reported that all the symptoms were mostly gone within 3 days. The patient did not receive any treatment for the events. The outcome of the events was resolved in Mar2021. No follow-up attempts are needed. No further information was expected.

Other Meds: ESTRADIOL; LISINOPRIL

Current Illness:

ID: 1823980
Sex: F
Age:
State: WV

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: shortness of breath; Redness at injection site; Large knot at injection site; Tingle down to my finger tips on arm with injection; Swollen lymph glands in the armpit of arm with injection; Heart palpitations; This is a spontaneous report received from a contactable consumer (Patient). A 42-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: EW0158) via an unspecified route of administration, administered in left arm on 08Apr2021 11:00 (at the age of 42-year-old) as dose 2, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included diabetes, high blood pressure from an unspecified date and unknown if ongoing. Patient received concomitant medications within 2 weeks of vaccination. Patient had no known allergies to medications, food, or other products. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: ER2613) via an unspecified route of administration, administered in Left arm on 19Mar2021 11:00 (at the age of 42-year-old) as dose 1, single for COVID-19 immunization. It was reported that on 09Apr2021 14:00 patient experienced Redness at injection site, large knot at injection site, Tingle down to my fingertips on arm with injection, Swollen lymph glands in the armpit of arm with injection, Heart palpitations and shortness of breath. Events were not serious. Patient did not receive treatment for the adverse event. Outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1823981
Sex: F
Age:
State: CT

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210409; Test Name: Body temperature; Result Unstructured Data: Test Result:99.4; Comments: Fever of 99.4 usu. 97.5

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: tiredness; Limited range of motion of arm without pain; Pain at injection site; fever of 99.4 usually 97.5; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, asthma, osteoarthritis, blood pressure high and COVID-19 from an unknown date and unknown if ongoing. The patient previously had wheat and sulfa and experienced allergy. Concomitant medications included Fluticasone Propionate/Salmeterol and salbutamol sulfate (ALBUTEROL SULFA), both from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 11Mar2021 at 11:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation and experienced severe headache, pain at injection site, limited range of motion of arm without pain. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 17:00, the patient experienced fever of 99.4 (units unspecified) usually 97.5 (units unspecified), pain at injection site, limited range of motion of arm without pain, tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of fever of 99.4 (units unspecified) usually 97.5 (units unspecified), pain at injection site, limited range of motion of arm without pain, tiredness and included treatment with acetaminophen, Biofreeze spray. The patient underwent lab tests and procedures which included body temperature 99.4 (units unspecified) on 09Apr2021. The clinical outcome of the events fever of 99.4 (units unspecified) usually 97.5 (units unspecified), pain at injection site, limited range of motion of arm without pain, tiredness was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: FLUTICASONE PROPIONATE/SALMETEROL; ALBUTEROL SULFATE

Current Illness:

ID: 1823982
Sex: F
Age:
State: CA

Vax Date: 03/16/2021
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Large hive/welt the size of a fist over the vaccine site in my left arm for 2+weeks; Hot; Itchy; Had large lump underneath; This is a spontaneous report from a contactable consumer(patient) or other non hcp. A 44-years-old female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6208), via an unspecified route of administration, administered in Arm Left on 16Mar2021 13:00 as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included hypertension, drug hypersensitivity for Sulfa. Concomitant medication(s) included losartan (LOSARTAN) and zolpidem (ZOLPIDEM). The patient previously took keflex [cefalexin monohydrate] and experienced drug hypersensitivity.The patient experienced large hive/welt the size of a fist over the vaccine site in his left arm for 2 plus weeks, hot, itchy and had large lump underneath on Apr2021. The events outcome was reported as not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; ZOLPIDEM

Current Illness:

ID: 1823983
Sex: F
Age:
State: PA

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210412; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Pain in extremity

Symptoms: fever; chills; extreme body aches; This is a spontaneous report from a contactable nurse. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 as a single dose for COVID-19 immunisation. Medical history included diabetes, hypothyroidism, mild asthma, extreme sensitivity to medications which was being monitored by an immunologist, COVID-19 and the patient had penicillin allergy from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (UNITHROID), insulin degludec (TRESIBA), metformin (MANUFACTURER UNKNOWN) and deflazacort (PRANDIN), all taken for unspecified indications from unknown dates. The patient previously took vancomycin, augmentin, bactrim, keflex and macrodantin and experienced drug allergy with all of these. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the day after the shot, the patient experienced fever, chills and extreme body aches for 24 to 48 hours. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. On 12Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The clinical outcome of the events fever, chills and extreme body aches were resolved on 21Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: UNITHROID; TRESIBA; METFORMIN; PRANDIN

Current Illness:

ID: 1823984
Sex: F
Age:
State: MN

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Date: 20210409; Test Name: fever of; Result Unstructured Data: Test Result: 104.1 Fahrenheit.

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: fever; chills; tired; achy body& muscles; headache; This is a spontaneous report from a non-contactable consumer. This consumer reported for herself that, A 49-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: ER8729), dose 2 via an unspecified route of administration, administered in arm left on 08Apr2021 16:45 as dose 2, single for covid-19 immunisation (age at the vaccination 49 years old). Historical vaccine, the patient took first dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot: ER2613), dose 1 via an unspecified route of administration, administered in arm left on 18Mar2021 17:00 as dose 1, single for covid-19 immunisation, the patient experienced tired. Medical history included asthma, post-traumatic stress disorder and fibromyalgia from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing. She also had known allergies to Sulfa, Vicodin and Dilaudid. Concomitant medication(s) included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported; fexofenadine hydrochloride (ALLEGRA) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR) taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) taken for an unspecified indication, start and stop date were not reported; formoterol fumarate, mometasone furoate (DULERA) taken for an unspecified indication, start and stop date were not reported. The patient previously took vicodin and experienced drug hypersensitivity, dilaudid and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation and experienced fatigue. It was reported that, after the second shot on 08Apr2021 following morning on 09Apr2021 04:00 patient experienced fever of 104.1 F, chills, tired, achy body & muscles and headache. She did not receive any treatment for the events. Lab data included, on 09Apr2021 patient experienced fever of 104.1 F. Patient did not take any other vaccine in four weeks. She did not have covid prior to vaccination. She was not tested for covid post vaccination. The outcome for the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: Zoloft; Allegra; Singulair; Flonase [Fluticasone Propionate]; Dulera

Current Illness:

ID: 1823985
Sex: F
Age:
State: PA

Vax Date: 02/25/2021
Onset Date: 03/02/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: 5 days after 1st dose started to itch on torso - started to abate till got the 2nd shot- am still having itching issues; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 80-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EM9809, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 25Feb2021 at 13:45 pm (age at vaccination was 80 years) as dose 1, single for COVID-19 immunization. The patient's medical history included known allergies to sulfa and penicillin. The patient received concomitant medications or other medications within 2 weeks of vaccination. The patient previously took macrobid [nitrofurantoin] and experienced allergy. The facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Mar2021, 5 days after 1st dose, the patient started to itch on torso. It started to abate till got the 2nd shot. The patient was still having itching issues. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment with topical creams. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6208, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 25Mar2021 (age at vaccination was unknown) as dose 2, single for COVID-19 immunization. The case was assessed as non-serious. The outcome of the event was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823986
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: chills; low grade fever; sleeping; He was tired; This is a spontaneous report from a contactable consumer or other non hcp. A 65-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date after 2 weeks of vaccination patient experienced sleeping on his, chills, low grade fever, tired. Patient had side effects were within the first 3 days which was normal. Patient had low grade fever and chills for 5 days. The outcome of the events was unknown. No Follow-up attempts are possible. Information about lot/batch number cannot be Obtained.

Other Meds:

Current Illness:

ID: 1823987
Sex: F
Age:
State: IN

Vax Date: 02/28/2021
Onset Date: 03/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Severe joint and muscle pain; Severe joint and muscle pain; tiredness; headache; This is a spontaneous report from a contactable consumer (patient) and other HCP. A 71-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: FN6200), via an unspecified route of administration, administered in arm left on 28Feb2021 at 09:30 AM (at the age of 71-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included diabetes, hx breast cancer, arthritis and allergy to xray contrast ionic and non-ionic. The patient received concomitant medication in two weeks which included metformin taken for an unspecified indication, start and stop date were not reported. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6199), via an unspecified route of administration, administered in arm left on 06Mar2021 as dose 2, single for COVID-19 immunization. The patient previously took valium, rocephin and experienced drug allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient was diagnosed with COVID prior vaccination. No COVID tested post vaccination. On 05Mar2021, the patient experienced severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr. No treatment was received in response to the adverse events. The outcome of all the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: METFORMIN

Current Illness:

ID: 1823988
Sex: F
Age:
State: FL

Vax Date: 03/10/2021
Onset Date: 03/13/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: decreased sense of smell; This is a Spontaneous report based on the information received by Pfizer from company (Manufacturer Control No: 2021-0405000266) via a contactable consumer (Patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: Solution for injection, Lot number and expiry date was not reported), via an unspecified route of administration on 10Mar2021 as dose 1, single for COVID-19 immunization. Medical history included nasal polyps due to which she suffered decreased sense of smell or taste and increased pain/pressure in the face or ears over last month. Concomitant medications were not reported. The patient stated sense of smell returned for 1 month but then disappeared on 13Mar2021 (3 days after taking the Pfizer Covid Vaccine shot). Outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness: Nasal polyps

ID: 1823989
Sex: M
Age:
State: FL

Vax Date: 04/09/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: This is a spontaneous report from a contactable consumer or other non healthcare professional. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 09Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever and got sick causing pyrexia on an unspecified date with outcome of unknown No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness:

ID: 1823990
Sex: M
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: He developed hypersensitivity of his skin; Stinging sensation all over his body; This is a spontaneous report from a contactable consumer (patient). A 85-years-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 for covid-19 immunisation on an unspecified date for covid-19 immunisation. On an unspecified date, the patient experienced developed hypersensitivity of his skin and stinging sensation all over his body. It was reported that, patient received both doses of the Covid vaccine and reports that no immediate reaction occurred. Reporter stated a couple of weeks after the second dose, on an unspecified date he developed hypersensitivity of his skin, in which he stated that it was bothersome when his pants to touch his legs and he had a stinging sensation all over his body. He stated that he saw a dermatologist, in which they stated that nothing was wrong with his skin and his general practitioner is clueless. He did not have a rash, hives, lesions, warmth, redness, or inflammation. He only had a hypersensitivity, and the vaccine had been the only new thing introduced to his body. He stated that his wife and himself took the vaccine and both doses were spaced more than the recommended period due to an unexpected freeze in (place). He stated that they received their vaccines 4 weeks apart. Reporter asked if there had been any similar reactions reported from the vaccine. Reporter asked how long did the hypersensitivity reactions last, if the reactions occurred immediately or delayed and if Pfizer had any treatment recommendations, if any autoimmune reactions have developed after the vaccine. Seriousness of events were reported as non-serious by the reporter. Outcome of events were unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1823991
Sex: M
Age:
State: OH

Vax Date: 04/09/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: having a fever; This is a Spontaneous report from a Pfizer sponsored program Support. A contactable consumer or other non-HCP (wife) reported for patient (Husband). A male patient of an unspecified age received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number: not reported), via an unspecified route of administration on 09Apr2021 as DOSE 2, SINGLE for covid-19 immunization. The relevant medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date, the patient having a fever. The caller reported that, her husband got the second dose yesterday which is 09Apr2021 and received the first dose 3 weeks ago. Caller did not mention the date of the first dose. Her husband was having a fever and she was getting information if her husband can take Tylenol. Outcome of the event was unknown. No follow-up attempts are possible. Information about lot/batch cannot be obtained.

Other Meds:

Current Illness:

ID: 1823992
Sex: F
Age:
State: NC

Vax Date: 03/03/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: This is a spontaneous report from a contactable Other Health Professional (patient). A 56-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZ-ER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Right on 03Mar2021 at 09:45 AM (at the age of 56-year-old), as DOSE 2, SINGLE for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included lyme disease from an unknown date and unknown if ongoing. The patient had allergies to clams and Sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other concomitant medications within two weeks. The patient had not received any other vaccine within 4 weeks. Since the vaccination, the patient had not been tested for COVID-19. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9264), via an unspecified route of administration, administered in Right arm on 09Feb2021 at 09:45 AM (at the age of 56-year-old) for covid-19 immunisation and had Pronounced joint pain with 1st injections, had an exaggeration of L lateral epicondylitis that was present at the time. From there, within 2 days wrist pain became pronounced bilaterally. Joint pain has become far worse in areas of her body that had older injuries and were not in pain at the time of the 1st injection. On an unspecified date in 2021, the patient experienced very pronounced left knee pain and left ankle pain/Currently suffering from right wrist pain. It was reported that after her second Covid 19 vaccination, developed very pronounced left knee pain and left ankle pain. Currently suffering from right wrist pain, exquisitely painful. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Voltaren gel for ankle were taken as a result of very pronounced left knee pain and left ankle pain. The events did not result into death, Life threatening, Caused/prolonged hospitalization, disabling/Incapacitating and congenital anomaly/birth defect. The case was reported as non-serious. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of pronounced left knee pain and left ankle pain/Currently suffering from right wrist pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am